carprofen has been researched along with Canine Diseases in 89 studies
carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the analgesic efficacy of grapiprant to carprofen for the treatment of postoperative pain and inflammation in dogs following ovariohysterectomy." | 9.51 | Preliminary evaluation of the effects of grapiprant compared with carprofen on acute pain and inflammation following ovariohysterectomy in dogs. ( Barnes, DN; Enomoto, H; Long, SM; Messenger, KM; Southern, BL, 2022) |
| "The aim of this study was to evaluate renal hemodynamics, routine clinical and laboratory parameters used to estimate renal function, and clinical evolution during six months in bitches with mammary carcinomas that underwent mastectomy and were treated (TG) or not (CG) with carprofen for three months after surgery." | 9.41 | Ultrasonographic assessment of renal perfusion in bitches with mammary carcinoma treated with long-term carprofen. ( Belchior Vela, D; De Nardi, AB; Firmo, BF; Gasser, B; Maronezi, MC; Nogueira Aires, LP; Pavan, L; Piovan Lima, G; Ramirez Uscategui, RA; Rossi Feliciano, MA; Vargas Estrada, CR, 2021) |
| "To investigate the ability of a proprietary antagonist of E-type prostanoid receptor (EP) 4, grapiprant, and carprofen to attenuate lameness attributable to urate-induced synovitis in dogs." | 9.30 | Comparison of two inhibitors of E-type prostanoid receptor four and carprofen in dogs with experimentally induced acute synovitis. ( Budsberg, SC; Kleine, SA; Norton, MM; Sandberg, GS, 2019) |
| "A multi-site, masked, randomised parallel group study employing a double dummy treatment design was performed in canine veterinary patients to determine the comparative efficacy and safety of mavacoxib and carprofen in the treatment of pain and inflammation associated with osteoarthritis for a period of 134 days." | 9.20 | Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis. ( Becskei, C; Chaudhry, Y; Payne-Johnson, M; Stegemann, MR, 2015) |
| "To determine the optimal method for use of the Canine Brief Pain Inventory (CBPI) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo." | 9.17 | Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis. ( Bell, M; Brown, DC; Rhodes, L, 2013) |
| " In this study, the efficacy and tolerability of robenacoxib were compared with those of carprofen in canine osteoarthritis in a multi-centre, prospective, randomized, blinded, positive-controlled noninferiority clinical trial." | 9.16 | Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. ( Gruet, P; King, JN; Reymond, N; Seewald, W; Speranza, C, 2012) |
| "The efficacy and tolerability of robenacoxib for the treatment of osteoarthritis in dogs were evaluated in a prospective, multicenter, randomized, noninferiority design clinical trial." | 9.16 | Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial. ( Edamura, K; King, JN; Okumura, M; Sakakibara, N; Seewald, W, 2012) |
| "Results suggested that in dogs with chronic osteoarthritis receiving carprofen because of signs of pain, feeding a diet supplemented with fish oil omega-3 fatty acids may allow for a reduction in carprofen dosage." | 9.14 | A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. ( Allen, TA; Brejda, J; Dodd, CE; Fritsch, DA; Hahn, KA; Jewell, DE; Leventhal, PS; Sixby, KA, 2010) |
| "A randomized, placebo-controlled, four-period cross-over laboratory study involving eight dogs was conducted to confirm the effective analgesic dose of firocoxib, a selective COX-2 inhibitor, in a synovitis model of arthritis." | 9.13 | Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs. ( Hanson, PD; Hazewinkel, HA; Pollmeier, M; Theyse, LF; van den Brom, WE, 2008) |
| "This positive-control study evaluated the efficacy of firocoxib versus carprofen, deracoxib, and meloxicam for the prevention of pain and inflammation in a urate crystal synovitis model of lameness." | 9.12 | Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs. ( Drag, M; Hanson, PD; Kunkle, BN; Romano, D, 2007) |
| "A double-blind, randomised, controlled, multicentre field study was conducted to compare the safety and efficacy of firocoxib chewable tablets and carprofen tablets in 218 dogs with osteoarthritis." | 9.12 | Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis. ( Fleishman, C; Hanson, PD; Pollmeier, M; Toulemonde, C, 2006) |
| "Thirty-five dogs were included in a randomised, double-blind, positive controlled, multi-centre trial to assess the efficacy of an orally-administered glucosamine hydrochloride and chondroitin sulfate (Glu/CS) combination for the treatment of confirmed osteoarthritis of hips or elbows." | 9.12 | Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. ( Jones, B; McAllister, H; McCarthy, G; Mooney, C; O'Donovan, J; Seed, M, 2007) |
| "The efficacy, tolerance and ease of administration of a nutraceutical, carprofen or meloxicam were evaluated in a prospective, double-blind study on 71 dogs with osteoarthritis." | 9.10 | Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. ( Bonneau, NH; Desnoyers, M; Dupuis, J; Moreau, M, 2003) |
| "Six medium to large breed dogs with osteoarthritis were treated with 2 mg/kg of racemic carprofen, mixed with their morning feed, daily for 28 days." | 9.10 | Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis. ( AliAbadi, FS; Lees, P; Lipscomb, VJ; Muir, P; Pead, MJ, 2002) |
| "The pain-relieving effect of carprofen and tolerance to the drug were investigated in 805 dogs that were lame as a result of osteoarthritis." | 7.74 | Long-term treatment with carprofen of 805 dogs with osteoarthritis. ( Grøndahl, C; Lønaas, L; Mansa, S; Nyman, G; Palmér, E, 2007) |
| "To evaluate in vivo activity of carprofen, deracoxib, and etodolac on prostanoid production in several target tissues in dogs with chronic osteoarthritis." | 7.73 | In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis. ( Budsberg, SC; Reynolds, LR; Sessions, JK, 2005) |
| "The purpose of this study was to evaluate the effect of the administration of meloxicam; carprofen; and a slow-acting disease modifying osteoarthritis agent, that contains chondroitin sulfate, purified glucosamine, and manganese ascorbate (CS-G-M), on thyroid function in dogs." | 7.72 | Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis. ( Beauchamp, G; Dupuis, J; Moreau, M; Paradis, M; Refsal, KR; Sauvé, F, 2003) |
| "To compare the analgesic and anti-inflammatory effect of single doses of carprofen, etodolac, meloxicam, and butorphanol in dogs with induced acute synovitis (acute pain model) via kinetic gait analysis and orthopedic evaluation and examine measurement of serum C-reactive protein (CRP) concentration as an indicator of treatment efficacy." | 7.72 | Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis. ( Borer, LR; Peel, JE; Schawalder, P; Seewald, W; Spreng, DE, 2003) |
| "To determine effects of carprofen and dexamethasone on chondrocytes in a culture model of osteoarthritis (OA)." | 7.71 | Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis. ( Cook, JL; Dvorak, LD; Kreeger, JM; Kuroki, K; Tomlinson, JL, 2002) |
| "Synovitis was induced in 1 stifle joint during each treatment by intra-articular injection of sodium urate (SU)." | 6.94 | Comparison of the effects on lameness of orally administered acetaminophen-codeine and carprofen in dogs with experimentally induced synovitis. ( Budsberg, SC; Kleine, SA; Norton, MM; Papich, MG; Sandberg, GS, 2020) |
| "Carprofen was also somewhat effective in attenuating the severity of urate-induced synovitis but to a lesser degree than the medium dose of deracoxib." | 6.70 | Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs. ( Buonomo, FC; Millis, DL; Moyers, T; Weigel, JP, 2002) |
| "Carprofen is a propionic acid-derived NSAID that has anti-inflammatory, analgesic, and antipyretic activity." | 6.40 | Use of carprofen for the treatment of pain and inflammation in dogs. ( Fox, SM; Johnston, SA, 1997) |
| "To compare the analgesic efficacy of grapiprant to carprofen for the treatment of postoperative pain and inflammation in dogs following ovariohysterectomy." | 5.51 | Preliminary evaluation of the effects of grapiprant compared with carprofen on acute pain and inflammation following ovariohysterectomy in dogs. ( Barnes, DN; Enomoto, H; Long, SM; Messenger, KM; Southern, BL, 2022) |
| " In explant culture, low MW HA combined with 12." | 5.42 | Effects of low molecular weight hyaluronan combined with carprofen on canine osteoarthritis articular chondrocytes and cartilage explants in vitro. ( Buddhachat, K; Chomdej, S; Euppayo, T; Harada, Y; Nganvongpanit, K; Ongchai, S; Pradit, W; Siengdee, P; Viriyakhasem, N, 2015) |
| "The aim of this study was to evaluate renal hemodynamics, routine clinical and laboratory parameters used to estimate renal function, and clinical evolution during six months in bitches with mammary carcinomas that underwent mastectomy and were treated (TG) or not (CG) with carprofen for three months after surgery." | 5.41 | Ultrasonographic assessment of renal perfusion in bitches with mammary carcinoma treated with long-term carprofen. ( Belchior Vela, D; De Nardi, AB; Firmo, BF; Gasser, B; Maronezi, MC; Nogueira Aires, LP; Pavan, L; Piovan Lima, G; Ramirez Uscategui, RA; Rossi Feliciano, MA; Vargas Estrada, CR, 2021) |
| "To investigate the ability of a proprietary antagonist of E-type prostanoid receptor (EP) 4, grapiprant, and carprofen to attenuate lameness attributable to urate-induced synovitis in dogs." | 5.30 | Comparison of two inhibitors of E-type prostanoid receptor four and carprofen in dogs with experimentally induced acute synovitis. ( Budsberg, SC; Kleine, SA; Norton, MM; Sandberg, GS, 2019) |
| "A multi-site, masked, randomised parallel group study employing a double dummy treatment design was performed in canine veterinary patients to determine the comparative efficacy and safety of mavacoxib and carprofen in the treatment of pain and inflammation associated with osteoarthritis for a period of 134 days." | 5.20 | Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis. ( Becskei, C; Chaudhry, Y; Payne-Johnson, M; Stegemann, MR, 2015) |
| "To determine the optimal method for use of the Canine Brief Pain Inventory (CBPI) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo." | 5.17 | Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis. ( Bell, M; Brown, DC; Rhodes, L, 2013) |
| "The efficacy and tolerability of robenacoxib for the treatment of osteoarthritis in dogs were evaluated in a prospective, multicenter, randomized, noninferiority design clinical trial." | 5.16 | Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial. ( Edamura, K; King, JN; Okumura, M; Sakakibara, N; Seewald, W, 2012) |
| " Our results suggest that analgesic treatment with ABT-116 is not as effective as carprofen or tramadol for treatment of hip arthritis pain in client-owned dogs." | 5.16 | Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. ( Bleedorn, JA; Cozzi, EM; Holzman, G; Jacobson, PB; Malek, S; Muir, P; Nemke, B; Sample, SJ; Schaefer, SL; Schwartz, Z, 2012) |
| " In this study, the efficacy and tolerability of robenacoxib were compared with those of carprofen in canine osteoarthritis in a multi-centre, prospective, randomized, blinded, positive-controlled noninferiority clinical trial." | 5.16 | Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. ( Gruet, P; King, JN; Reymond, N; Seewald, W; Speranza, C, 2012) |
| " In the carprofen and placebo groups, there was poor correlation between the 2 pain evaluation methods (VAS and HCPI items) at the baseline evaluation, but the correlation improved in the carprofen group over time." | 5.15 | Reliability and validity of a visual analogue scale used by owners to measure chronic pain attributable to osteoarthritis in their dogs. ( Hielm-Björkman, AK; Kapatkin, AS; Rita, HJ, 2011) |
| "To determine whether carprofen, a commercially available NSAID, would decrease perceived exertion and signs of pain in dogs and therefore increase muscle mass and hind limb function without decreasing range of motion after lateral fabellar suture stabilization." | 5.15 | Effect of the use of carprofen in dogs undergoing intense rehabilitation after lateral fabellar suture stabilization. ( Dunning, D; Gordon-Evans, WJ; Johnson, AL; Knap, KE, 2011) |
| "Results suggested that in dogs with chronic osteoarthritis receiving carprofen because of signs of pain, feeding a diet supplemented with fish oil omega-3 fatty acids may allow for a reduction in carprofen dosage." | 5.14 | A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. ( Allen, TA; Brejda, J; Dodd, CE; Fritsch, DA; Hahn, KA; Jewell, DE; Leventhal, PS; Sixby, KA, 2010) |
| "To determine whether an activity monitor (AM) could be used to detect changes in activity in dogs with osteoarthritis treated with carprofen or a placebo." | 5.14 | Use of an activity monitor to detect response to treatment in dogs with osteoarthritis. ( Boston, RC; Brown, DC; Farrar, JT, 2010) |
| "A randomized, placebo-controlled, four-period cross-over laboratory study involving eight dogs was conducted to confirm the effective analgesic dose of firocoxib, a selective COX-2 inhibitor, in a synovitis model of arthritis." | 5.13 | Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs. ( Hanson, PD; Hazewinkel, HA; Pollmeier, M; Theyse, LF; van den Brom, WE, 2008) |
| "Thirty-five dogs were included in a randomised, double-blind, positive controlled, multi-centre trial to assess the efficacy of an orally-administered glucosamine hydrochloride and chondroitin sulfate (Glu/CS) combination for the treatment of confirmed osteoarthritis of hips or elbows." | 5.12 | Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. ( Jones, B; McAllister, H; McCarthy, G; Mooney, C; O'Donovan, J; Seed, M, 2007) |
| "A double-blind, randomised, controlled, multicentre field study was conducted to compare the safety and efficacy of firocoxib chewable tablets and carprofen tablets in 218 dogs with osteoarthritis." | 5.12 | Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis. ( Fleishman, C; Hanson, PD; Pollmeier, M; Toulemonde, C, 2006) |
| "This positive-control study evaluated the efficacy of firocoxib versus carprofen, deracoxib, and meloxicam for the prevention of pain and inflammation in a urate crystal synovitis model of lameness." | 5.12 | Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs. ( Drag, M; Hanson, PD; Kunkle, BN; Romano, D, 2007) |
| "The efficacy, tolerance and ease of administration of a nutraceutical, carprofen or meloxicam were evaluated in a prospective, double-blind study on 71 dogs with osteoarthritis." | 5.10 | Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. ( Bonneau, NH; Desnoyers, M; Dupuis, J; Moreau, M, 2003) |
| "Six medium to large breed dogs with osteoarthritis were treated with 2 mg/kg of racemic carprofen, mixed with their morning feed, daily for 28 days." | 5.10 | Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis. ( AliAbadi, FS; Lees, P; Lipscomb, VJ; Muir, P; Pead, MJ, 2002) |
| "To describe a serious adverse event of gastrointestinal obstruction requiring surgery following routine administration of multiple doses of activated charcoal (AC) granules, which were prescribed for carprofen toxicosis." | 3.96 | Gastrointestinal obstruction secondary to activated charcoal granule impaction in a dog. ( Burkitt-Creedon, JM; Farrell, KS; Gibson, EA; Massie, AM; Osborne, LG, 2020) |
| "The pain-relieving effect of carprofen and tolerance to the drug were investigated in 805 dogs that were lame as a result of osteoarthritis." | 3.74 | Long-term treatment with carprofen of 805 dogs with osteoarthritis. ( Grøndahl, C; Lønaas, L; Mansa, S; Nyman, G; Palmér, E, 2007) |
| "To evaluate in vivo activity of carprofen, deracoxib, and etodolac on prostanoid production in several target tissues in dogs with chronic osteoarthritis." | 3.73 | In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis. ( Budsberg, SC; Reynolds, LR; Sessions, JK, 2005) |
| "To compare the analgesic and anti-inflammatory effect of single doses of carprofen, etodolac, meloxicam, and butorphanol in dogs with induced acute synovitis (acute pain model) via kinetic gait analysis and orthopedic evaluation and examine measurement of serum C-reactive protein (CRP) concentration as an indicator of treatment efficacy." | 3.72 | Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis. ( Borer, LR; Peel, JE; Schawalder, P; Seewald, W; Spreng, DE, 2003) |
| "The purpose of this study was to evaluate the effect of the administration of meloxicam; carprofen; and a slow-acting disease modifying osteoarthritis agent, that contains chondroitin sulfate, purified glucosamine, and manganese ascorbate (CS-G-M), on thyroid function in dogs." | 3.72 | Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis. ( Beauchamp, G; Dupuis, J; Moreau, M; Paradis, M; Refsal, KR; Sauvé, F, 2003) |
| "To determine effects of carprofen and dexamethasone on chondrocytes in a culture model of osteoarthritis (OA)." | 3.71 | Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis. ( Cook, JL; Dvorak, LD; Kreeger, JM; Kuroki, K; Tomlinson, JL, 2002) |
| "Postoperative pain was assessed using the Glasgow Composite Pain Scale-Short Form (GCPS-SF) at extubation and 2, 4, 6, 8, 18, and 24 hours postextubation and compared to baseline." | 3.11 | Evaluation of the perioperative analgesic effects of grapiprant compared with carprofen in dogs undergoing elective ovariohysterectomy. ( DeBolt, RK; Hendrix, E; Kleine, SA; Ross, JM; Seddighi, R; Smith, CK; Weisent, J, 2022) |
| "Synovitis was induced in 1 stifle joint during each treatment by intra-articular injection of sodium urate (SU)." | 2.94 | Comparison of the effects on lameness of orally administered acetaminophen-codeine and carprofen in dogs with experimentally induced synovitis. ( Budsberg, SC; Kleine, SA; Norton, MM; Papich, MG; Sandberg, GS, 2020) |
| "Carprofen was administered to Group CG for 70 days, at a dose adjusted to their weight." | 2.87 | Evaluation of the effect of mesotherapy in the management of back pain in police working dog. ( Alves, JC; Dos Santos, AM; Fernandes, ÂD, 2018) |
| "Prednisone-treated dogs were more likely to develop polyuria, polydipsia, and polyphagia than were cyclosporine-treated dogs." | 2.82 | Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis. ( Herrera, MA; Kass, PH; Rhoades, AC; Sykes, JE; Vernau, W, 2016) |
| "Flunixin meglumine was more effective than meloxicam or carprofen for minimizing the PGE(2) concentration in the aqueous humor of dogs with experimentally induced uveitis." | 2.77 | Comparison of the effects of IV administration of meloxicam, carprofen, and flunixin meglumine on prostaglandin E(2) concentration in aqueous humor of dogs with aqueocentesis-induced anterior uveitis. ( Gilmour, MA; Payton, ME, 2012) |
| "On the fourth day after initiation of treatment, synovitis was induced via intra-articular injection of SU 1 hour before administration of the last treatment dose." | 2.76 | Effect of perzinfotel and a proprietary phospholipase A(2) inhibitor on kinetic gait and subjective lameness scores in dogs with sodium urate-induced synovitis. ( Al-Nadaf, S; Budsberg, SC; Cathcart, CJ; Clark, JD; Eppler, CM; Reynolds, LR; Torres, BT; Zwijnenberg, RJ, 2011) |
| "Tepoxalin was more effective than carprofen or meloxicam for controlling the production of PGE(2) in dogs with experimentally induced uveitis." | 2.74 | Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs. ( Gilmour, MA; Lehenbauer, TW, 2009) |
| "Treatment with carprofen decreased clot strength and platelet aggregation." | 2.73 | Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. ( Brainard, BM; Budsberg, SC; Callan, MB; Driessen, B; Meredith, CP; Otto, CM; Shofer, FS, 2007) |
| "To evaluate adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs." | 2.73 | Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. ( Basílio, AC; Brandão, CV; Luna, SP; Machado, LP; Moutinho, FQ; Steagall, PV; Takahira, RK, 2007) |
| "To evaluate the adverse effects of carprofen in dogs after oral administration for 2 months." | 2.72 | Evaluation of adverse effects of long-term orally administered carprofen in dogs. ( Hielm-Björkman, AK; Kejonen, J; Raekallio, MR; Salonen, HM; Sankari, SM, 2006) |
| "Carprofen did not cause clinically relevant adverse effects in dogs anesthetized for fracture repair after 5 days of treatment, even when it was administered before surgery or given to patients with trauma-induced alterations in renal function or hemostasis." | 2.71 | Effects of preoperative administration of carprofen on renal function and hemostasis in dogs undergoing surgery for fracture repair. ( Bergmann, HM; Kramer, S; Nolte, IJ, 2005) |
| "Carprofen was also somewhat effective in attenuating the severity of urate-induced synovitis but to a lesser degree than the medium dose of deracoxib." | 2.70 | Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs. ( Buonomo, FC; Millis, DL; Moyers, T; Weigel, JP, 2002) |
| "Carprofen is a propionic acid-derived NSAID that has anti-inflammatory, analgesic, and antipyretic activity." | 2.40 | Use of carprofen for the treatment of pain and inflammation in dogs. ( Fox, SM; Johnston, SA, 1997) |
| "Carprofen levels were determined by high-pressure liquid chromatography." | 1.72 | Successful management of severe carprofen toxicity with manual therapeutic plasma exchange in a dog. ( Blong, AE; Buseman, M; Walton, RAL, 2022) |
| " The objective of this study was to determine the unbound concentration of carprofen in canine interstitial fluid (ISF) using in vivo ultrafiltration and to compare pharmacokinetic parameters of free carprofen concentrations between inflamed and control tissue sites." | 1.43 | Carprofen pharmacokinetics in plasma and in control and inflamed canine tissue fluid using in vivo ultrafiltration. ( Messenger, KM; Papich, MG; Wofford, JA, 2016) |
| " In explant culture, low MW HA combined with 12." | 1.42 | Effects of low molecular weight hyaluronan combined with carprofen on canine osteoarthritis articular chondrocytes and cartilage explants in vitro. ( Buddhachat, K; Chomdej, S; Euppayo, T; Harada, Y; Nganvongpanit, K; Ongchai, S; Pradit, W; Siengdee, P; Viriyakhasem, N, 2015) |
| "Carprofen was detected in serum and plasma samples obtained from the dog." | 1.39 | Suspected carprofen toxicosis caused by coprophagia in a dog. ( Hutchins, RG; Messenger, KM; Vaden, SL, 2013) |
| "Carprofen treatment had no effect on platelet aggregation while ketoprofen decreased the aggregation maximum." | 1.35 | Influencing factors of ADP-induced, epinephrine-induced and ristomycin-induced platelet aggregation in dogs. ( Gaál, T; Halmay, D; Kocsis, R, 2008) |
| "Suspected adverse reactions (SARs) reported for Cartrophen Vet (100 mg sodium pentosan polysulphate/ml) to the Veterinary Medicines Directorate in the UK for the period January 1991 to October 1999 were reviewed." | 1.32 | Safety of Cartrophen Vet in the dog: review of adverse reaction reports in the UK. ( Cawdery, MJ; Cullis-Hill, D; Ghosh, P; Hannon, RL; Smith, JG, 2003) |
| " ML-1,785,713 had high oral bioavailability (101%), low systemic clearance (77 mL/min/kg), and an elimination half-life of 5." | 1.32 | In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. ( Andersen, DR; Black, WC; Brideau, C; Hanson, PD; Hickey, GJ; McCann, ME; Zhang, D, 2004) |
| "Carprofen has a direct influence on chondrocyte activity, resulting in changes in rate of production of cartilage matrix." | 1.30 | Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes. ( Benton, HP; Broderick-Villa, GA; Koolpe, M; Vasseur, PB, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (7.87) | 18.2507 |
| 2000's | 31 (34.83) | 29.6817 |
| 2010's | 41 (46.07) | 24.3611 |
| 2020's | 10 (11.24) | 2.80 |
| Authors | Studies |
|---|---|
| Meinke, PT | 1 |
| Vargas Estrada, CR | 1 |
| Firmo, BF | 1 |
| Belchior Vela, D | 1 |
| Maronezi, MC | 1 |
| Ramirez Uscategui, RA | 1 |
| Gasser, B | 1 |
| Rossi Feliciano, MA | 1 |
| Pavan, L | 1 |
| Nogueira Aires, LP | 1 |
| Piovan Lima, G | 1 |
| De Nardi, AB | 1 |
| Buseman, M | 1 |
| Blong, AE | 1 |
| Walton, RAL | 1 |
| Southern, BL | 1 |
| Long, SM | 1 |
| Barnes, DN | 1 |
| Enomoto, H | 2 |
| Messenger, KM | 4 |
| Ross, JM | 1 |
| Kleine, SA | 3 |
| Smith, CK | 1 |
| DeBolt, RK | 1 |
| Weisent, J | 1 |
| Hendrix, E | 1 |
| Seddighi, R | 1 |
| Budsberg, SC | 7 |
| Norton, MM | 2 |
| Sandberg, GS | 2 |
| White, C | 1 |
| Morrow, L | 1 |
| Fick, ME | 1 |
| Vigani, A | 1 |
| Farrell, KS | 1 |
| Burkitt-Creedon, JM | 1 |
| Osborne, LG | 1 |
| Gibson, EA | 1 |
| Massie, AM | 1 |
| Papich, MG | 3 |
| Jones, SM | 1 |
| Gaier, A | 1 |
| Ishii, P | 1 |
| Pilla, R | 1 |
| Price, J | 1 |
| Suchodolski, J | 1 |
| Steiner, JM | 2 |
| Messenger, K | 1 |
| Tolbert, MK | 1 |
| Raušer, P | 1 |
| Fichtel, T | 1 |
| Mauler, DA | 1 |
| De Decker, S | 1 |
| De Risio, L | 1 |
| Volk, HA | 2 |
| Dennis, R | 1 |
| Gielen, I | 1 |
| Van der Vekens, E | 1 |
| Goethals, K | 1 |
| Van Ham, L | 1 |
| Alves, JC | 2 |
| Dos Santos, AM | 1 |
| Fernandes, ÂD | 1 |
| Ensor, M | 1 |
| Lee, AM | 1 |
| Perkins, JM | 1 |
| Garcia, G | 1 |
| Beasley, MJ | 1 |
| Gambino, JM | 1 |
| Santos, AM | 1 |
| Jorge, PI | 1 |
| Kjaergaard, AB | 1 |
| Davis, JL | 1 |
| Acierno, MJ | 1 |
| Belshaw, Z | 1 |
| Brennan, M | 1 |
| AlRaddadi, EA | 1 |
| Winter, T | 1 |
| Aukema, HM | 1 |
| Miller, DW | 1 |
| Banovic, F | 1 |
| Linder, K | 1 |
| Boone, A | 1 |
| Jennings, S | 1 |
| Murphy, KM | 1 |
| Komnenou, AT | 1 |
| Kazakos, GM | 1 |
| Savvas, I | 1 |
| Thomas, AL | 1 |
| Hutchins, RG | 1 |
| Vaden, SL | 1 |
| Brown, DC | 4 |
| Bell, M | 1 |
| Rhodes, L | 1 |
| Kim, J | 1 |
| Kwon, SY | 1 |
| Cena, R | 1 |
| Park, S | 1 |
| Oh, J | 1 |
| Oui, H | 1 |
| Cho, KO | 1 |
| Min, JJ | 1 |
| Choi, J | 1 |
| Falkenö, U | 1 |
| Tvedten, HW | 1 |
| Spångberg, C | 1 |
| Payne-Johnson, M | 1 |
| Becskei, C | 1 |
| Chaudhry, Y | 1 |
| Stegemann, MR | 1 |
| Delgado, C | 1 |
| Bentley, E | 1 |
| Hetzel, S | 1 |
| Smith, LJ | 1 |
| Monotti, IC | 1 |
| Davies, SE | 1 |
| Lidbetter, DA | 1 |
| Bruno, EA | 1 |
| Guthrie, JW | 1 |
| Ellwood, SA | 1 |
| Mellanby, RJ | 1 |
| Clements, DN | 1 |
| Kalchofner Guerrero, KS | 1 |
| Schwarz, A | 1 |
| Wuhrmann, R | 1 |
| Feldmann, S | 1 |
| Hartnack, S | 1 |
| Bettschart-Wolfensberger, R | 1 |
| Alessio, TL | 1 |
| Krieger, EM | 1 |
| Wofford, JA | 1 |
| Euppayo, T | 1 |
| Siengdee, P | 1 |
| Buddhachat, K | 1 |
| Pradit, W | 1 |
| Viriyakhasem, N | 1 |
| Chomdej, S | 1 |
| Ongchai, S | 1 |
| Harada, Y | 1 |
| Nganvongpanit, K | 1 |
| Karrasch, NM | 1 |
| Lerche, P | 1 |
| Aarnes, TK | 1 |
| Gardner, HL | 1 |
| London, CA | 1 |
| Rhoades, AC | 1 |
| Vernau, W | 1 |
| Kass, PH | 1 |
| Herrera, MA | 1 |
| Sykes, JE | 1 |
| Weil, C | 1 |
| Tünsmeyer, J | 1 |
| Tipold, A | 1 |
| Hoppe, S | 1 |
| Beyerbach, M | 1 |
| Pankow, WR | 1 |
| Kästner, SB | 1 |
| Teixeira, LR | 1 |
| Luna, SP | 2 |
| Matsubara, LM | 1 |
| Cápua, ML | 1 |
| Santos, BP | 1 |
| Mesquita, LR | 1 |
| Faria, LG | 1 |
| Agostinho, FS | 1 |
| Hielm-Björkman, A | 1 |
| Yoshitake, R | 1 |
| Saeki, K | 1 |
| Watanabe, M | 1 |
| Nakaoka, N | 1 |
| Ong, SM | 1 |
| Hanafusa, M | 1 |
| Choisunirachon, N | 1 |
| Fujita, N | 1 |
| Nishimura, R | 1 |
| Nakagawa, T | 1 |
| Boston, RC | 2 |
| Coyne, JC | 1 |
| Farrar, JT | 2 |
| Gilmour, MA | 2 |
| Lehenbauer, TW | 1 |
| Fritsch, DA | 1 |
| Allen, TA | 1 |
| Dodd, CE | 1 |
| Jewell, DE | 1 |
| Sixby, KA | 1 |
| Leventhal, PS | 1 |
| Brejda, J | 1 |
| Hahn, KA | 1 |
| Reymond, N | 1 |
| Speranza, C | 1 |
| Gruet, P | 1 |
| Seewald, W | 3 |
| King, JN | 2 |
| Hielm-Björkman, AK | 2 |
| Kapatkin, AS | 1 |
| Rita, HJ | 1 |
| Torres, BT | 1 |
| Zwijnenberg, RJ | 1 |
| Eppler, CM | 1 |
| Clark, JD | 1 |
| Cathcart, CJ | 1 |
| Reynolds, LR | 2 |
| Al-Nadaf, S | 1 |
| Gordon-Evans, WJ | 1 |
| Dunning, D | 1 |
| Johnson, AL | 2 |
| Knap, KE | 1 |
| Harris, KP | 1 |
| Saveraid, TC | 1 |
| Rodenas, S | 1 |
| Payton, ME | 1 |
| Grozdanic, S | 1 |
| Riedesel, EA | 1 |
| Ackermann, MR | 1 |
| Edamura, K | 1 |
| Sakakibara, N | 1 |
| Okumura, M | 1 |
| Defontis, M | 1 |
| Richartz, J | 1 |
| Engelmann, N | 1 |
| Bauer, C | 1 |
| Schwierk, VM | 1 |
| Büscher, P | 1 |
| Moritz, A | 1 |
| Malek, S | 1 |
| Sample, SJ | 1 |
| Schwartz, Z | 1 |
| Nemke, B | 1 |
| Jacobson, PB | 1 |
| Cozzi, EM | 1 |
| Schaefer, SL | 1 |
| Bleedorn, JA | 1 |
| Holzman, G | 1 |
| Muir, P | 2 |
| Plessas, IN | 1 |
| Rusbridge, C | 1 |
| Driver, CJ | 1 |
| Chandler, KE | 1 |
| Craig, A | 1 |
| McGonnell, IM | 1 |
| Brodbelt, DC | 1 |
| Dvorak, LD | 1 |
| Cook, JL | 1 |
| Kreeger, JM | 1 |
| Kuroki, K | 1 |
| Tomlinson, JL | 1 |
| Millis, DL | 1 |
| Weigel, JP | 1 |
| Moyers, T | 1 |
| Buonomo, FC | 1 |
| Moreau, M | 2 |
| Dupuis, J | 4 |
| Bonneau, NH | 2 |
| Desnoyers, M | 1 |
| Hannon, RL | 1 |
| Smith, JG | 1 |
| Cullis-Hill, D | 1 |
| Ghosh, P | 1 |
| Cawdery, MJ | 1 |
| Sauvé, F | 1 |
| Paradis, M | 1 |
| Refsal, KR | 1 |
| Beauchamp, G | 1 |
| Murphy, KF | 1 |
| German, AJ | 1 |
| Ruaux, CG | 1 |
| Williams, DA | 1 |
| Hall, EJ | 1 |
| Grisneaux, E | 2 |
| Pibarot, P | 2 |
| Charette, B | 1 |
| Blais, D | 2 |
| Borer, LR | 1 |
| Peel, JE | 1 |
| Schawalder, P | 1 |
| Spreng, DE | 1 |
| McCann, ME | 1 |
| Andersen, DR | 1 |
| Zhang, D | 1 |
| Brideau, C | 1 |
| Black, WC | 1 |
| Hanson, PD | 4 |
| Hickey, GJ | 1 |
| Laredo, FG | 1 |
| Belda, E | 1 |
| Murciano, J | 1 |
| Escobar, M | 1 |
| Navarro, A | 1 |
| Robinson, KJ | 1 |
| Jones, RS | 1 |
| Mellor, PJ | 1 |
| Roulois, AJ | 1 |
| Day, MJ | 1 |
| Blacklaws, BA | 1 |
| Knivett, SJ | 1 |
| Herrtage, ME | 1 |
| Sessions, JK | 1 |
| Bergmann, HM | 1 |
| Nolte, IJ | 1 |
| Kramer, S | 1 |
| Nakagawa, K | 1 |
| Yamagami, T | 1 |
| Takemura, N | 1 |
| Raekallio, MR | 1 |
| Kejonen, J | 1 |
| Salonen, HM | 1 |
| Sankari, SM | 1 |
| McCarthy, G | 1 |
| O'Donovan, J | 1 |
| Jones, B | 1 |
| McAllister, H | 1 |
| Seed, M | 1 |
| Mooney, C | 1 |
| Akerblom, S | 1 |
| Sjöström, L | 1 |
| Dowers, KL | 1 |
| Uhrig, SR | 1 |
| Mama, KR | 1 |
| Gaynor, JS | 1 |
| Hellyer, PW | 1 |
| Pollmeier, M | 2 |
| Toulemonde, C | 1 |
| Fleishman, C | 1 |
| Brainard, BM | 1 |
| Meredith, CP | 1 |
| Callan, MB | 1 |
| Shofer, FS | 1 |
| Driessen, B | 1 |
| Otto, CM | 1 |
| Basílio, AC | 1 |
| Steagall, PV | 1 |
| Machado, LP | 1 |
| Moutinho, FQ | 1 |
| Takahira, RK | 1 |
| Brandão, CV | 1 |
| Mansa, S | 1 |
| Palmér, E | 1 |
| Grøndahl, C | 1 |
| Lønaas, L | 1 |
| Nyman, G | 1 |
| Hazewinkel, HA | 1 |
| van den Brom, WE | 1 |
| Theyse, LF | 1 |
| Drag, M | 1 |
| Kunkle, BN | 1 |
| Romano, D | 1 |
| Liesegang, A | 1 |
| Limacher, S | 1 |
| Sobek, A | 1 |
| Halmay, D | 1 |
| Gaál, T | 1 |
| Kocsis, R | 1 |
| Vasseur, PB | 2 |
| Lincoln, JD | 1 |
| Toombs, JP | 1 |
| Whitehair, JG | 1 |
| Lentz, EL | 1 |
| Lascelles, BD | 1 |
| Butterworth, SJ | 1 |
| Waterman, AE | 1 |
| Benton, HP | 1 |
| Broderick-Villa, GA | 1 |
| Koolpe, M | 1 |
| Fox, SM | 1 |
| Johnston, SA | 1 |
| MacPhail, CM | 1 |
| Lappin, MR | 1 |
| Meyer, DJ | 1 |
| Smith, SG | 1 |
| Webster, CR | 1 |
| Armstrong, PJ | 1 |
| Firth, AM | 1 |
| Haldane, SL | 1 |
| Lipscomb, VJ | 1 |
| AliAbadi, FS | 1 |
| Lees, P | 1 |
| Pead, MJ | 1 |
4 reviews available for carprofen and Canine Diseases
| Article | Year |
|---|---|
Perspectives in animal health: old targets and new opportunities.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Anti-Ulcer Age | 2001 |
Efficacy of meloxicam compared with carprofen for treating canine osteoarthritis.
Topics: Animals; Carbazoles; Dog Diseases; Dogs; Meloxicam; Osteoarthritis; Randomized Controlled Trials as | 2020 |
Villonodular synovitis in the dog: a report of four cases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Carbazoles; Dog Diseases; Dogs; Drug | 2006 |
Use of carprofen for the treatment of pain and inflammation in dogs.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 1997 |
47 trials available for carprofen and Canine Diseases
| Article | Year |
|---|---|
Ultrasonographic assessment of renal perfusion in bitches with mammary carcinoma treated with long-term carprofen.
Topics: Animals; Carbazoles; Carcinoma; Dog Diseases; Dogs; Female; Kidney; Mammary Glands, Animal; Mammary | 2021 |
Preliminary evaluation of the effects of grapiprant compared with carprofen on acute pain and inflammation following ovariohysterectomy in dogs.
Topics: Acute Pain; Animals; Carbazoles; Dinoprostone; Dog Diseases; Dogs; Female; Hysterectomy; Imidazoles; | 2022 |
Evaluation of the perioperative analgesic effects of grapiprant compared with carprofen in dogs undergoing elective ovariohysterectomy.
Topics: Analgesics; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Female; Hysterectomy; Ovariectomy; Pain | 2022 |
Comparison of two inhibitors of E-type prostanoid receptor four and carprofen in dogs with experimentally induced acute synovitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cross-Over Studies; Dog Diseases; Dogs | 2019 |
Comparison of the effects on lameness of orally administered acetaminophen-codeine and carprofen in dogs with experimentally induced synovitis.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Codeine; Cross-Over Stu | 2020 |
The effect of combined carprofen and omeprazole administration on gastrointestinal permeability and inflammation in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Female; Inflammati | 2020 |
Early Analgesic Efficacy of Morphine, Butorphanol, Lidocaine, Bupivacaine or Carprofen After Periodontal Treatment in Dogs.
Topics: Analgesics; Anesthetics, Local; Animals; Bupivacaine; Butorphanol; Carbazoles; Dog Diseases; Dogs; D | 2020 |
Evaluation of the effect of mesotherapy in the management of back pain in police working dog.
Topics: Analgesics; Animals; Back Pain; Carbazoles; Colchicine; Dexamethasone; Dog Diseases; Dogs; Drug Ther | 2018 |
Effect of an Oral Joint Supplement When Compared to Carprofen in the Management of Hip Osteoarthritis in Working Dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Chondroitin Sulfates; Dietary Suppleme | 2017 |
Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Do | 2013 |
The Canine Orthopedic Index. Step 3: Responsiveness testing.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cohort Studies; Data Collection; Dog D | 2014 |
Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double-Blind Metho | 2015 |
Comparison of carprofen and tramadol for postoperative analgesia in dogs undergoing enucleation.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs | 2014 |
Comparison of a new metamizole formulation and carprofen for extended post-operative analgesia in dogs undergoing ovariohysterectomy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Delayed-Action Preparations; Dipyrone; | 2015 |
The effects of preoperative oral administration of carprofen or tramadol on postoperative analgesia in dogs undergoing cutaneous tumor removal.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs | 2015 |
Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agent | 2016 |
Effects of concurrent perioperative use of marbofloxacin and cimicoxib or carprofen in dogs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; D | 2016 |
Owner assessment of chronic pain intensity and results of gait analysis of dogs with hip dysplasia treated with acupuncture.
Topics: Acupuncture Therapy; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Chronic Pain; Dog | 2016 |
Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double-Blind Metho | 2008 |
Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dinoprostone; Dog Diseases; Dogs; Melo | 2009 |
A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis.
Topics: Animals; Carbazoles; Dietary Supplements; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug | 2010 |
Use of an activity monitor to detect response to treatment in dogs with osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Female; Male; Moni | 2010 |
Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Diphenylamine; Dog Diseases; Dogs; Fem | 2012 |
Reliability and validity of a visual analogue scale used by owners to measure chronic pain attributable to osteoarthritis in their dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Chronic Disease; Dog Diseases; Dogs; F | 2011 |
Effect of perzinfotel and a proprietary phospholipase A(2) inhibitor on kinetic gait and subjective lameness scores in dogs with sodium urate-induced synovitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azabicyclo Compounds; Blood Proteins; Carbazoles; | 2011 |
Effect of the use of carprofen in dogs undergoing intense rehabilitation after lateral fabellar suture stabilization.
Topics: Animals; Anterior Cruciate Ligament; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomen | 2011 |
Comparison of the effects of IV administration of meloxicam, carprofen, and flunixin meglumine on prostaglandin E(2) concentration in aqueous humor of dogs with aqueocentesis-induced anterior uveitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Carbazoles; Clonixin; Dinoprostone; | 2012 |
Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.
Topics: Administration, Oral; Analysis of Variance; Animals; Carbazoles; Diphenylamine; Dog Diseases; Dogs; | 2012 |
Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Carbazoles; | 2012 |
Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cyclooxygenase I | 2002 |
Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Carbazoles; C | 2003 |
Effects of postoperative administration of ketoprofen or carprofen on short- and long-term results of femoral head and neck excision in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double-Blind Metho | 2003 |
Comparison of the analgesic effects of meloxicam and carprofen administered preoperatively to dogs undergoing orthopaedic surgery.
Topics: Animals; Anterior Cruciate Ligament; Carbazoles; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Drug | 2004 |
Effects of preoperative administration of carprofen on renal function and hemostasis in dogs undergoing surgery for fracture repair.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Female; Fractures, | 2005 |
Evaluation of adverse effects of long-term orally administered carprofen in dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Carbazoles; | 2006 |
Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Chondroitin Sulf | 2007 |
Effect of short-term sequential administration of nonsteroidal anti-inflammatory drugs on the stomach and proximal portion of the duodenum in healthy dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cross-Over Studi | 2006 |
Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; D | 2006 |
Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs.
Topics: Animals; Aspirin; Carbazoles; Cross-Over Studies; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Fem | 2007 |
Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Coagulation; Carbazole | 2007 |
Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Carbazoles; Cross-Over | 2008 |
Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
Topics: 4-Butyrolactone; Animals; Carbazoles; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Lamen | 2007 |
Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Female; Male; Oste | 1995 |
Postoperative analgesic and sedative effects of carprofen and pethidine in dogs.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double- | 1994 |
Development of a scale to evaluate postoperative pain in dogs.
Topics: Acepromazine; Analgesics, Opioid; Anesthesia, General; Animals; Anti-Inflammatory Agents, Non-Steroi | 1999 |
Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleeding Time; Blood Loss, Surgical; Blood Pressur | 1999 |
Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Breeding; | 2002 |
38 other studies available for carprofen and Canine Diseases
| Article | Year |
|---|---|
Successful management of severe carprofen toxicity with manual therapeutic plasma exchange in a dog.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apomorphine; Carbazoles; Charcoal; Cholestyramine | 2022 |
Efficacy of a single session in-series hemoperfusion and hemodialysis in the management of carprofen overdose in two dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Charcoal; Dog Diseases; Dogs; Hemoperf | 2020 |
Gastrointestinal obstruction secondary to activated charcoal granule impaction in a dog.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Charcoal; Diarrhea; Digestive System S | 2020 |
Spinal Arachnoid Diverticula: Outcome in 96 Medically or Surgically Treated Dogs.
Topics: Amines; Animals; Arachnoid Cysts; Carbazoles; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; Femal | 2017 |
What Is Your Neurologic Diagnosis?
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Apico | 2018 |
Treatment of carprofen overdose with therapeutic plasma exchange in a dog.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Diagnosis, Differential; Dog Diseases; | 2018 |
Are nutraceuticals better than carprofen at controlling osteoarthritis in dogs?
Topics: Animals; Carbazoles; Clinical Decision-Making; Controlled Clinical Trials as Topic; Dietary Suppleme | 2018 |
Effects of various dietary supplements on inflammatory processes in primary canine chondrocytes as a model of osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cell Survival; Cells, Cultured; Chondr | 2019 |
Cat scratch-induced Pasteurella multocida necrotizing cellulitis in a dog.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cat-Scratch Dis | 2013 |
Evaluation of aqueous tear production in dogs after general anaesthesia with medetomidine-propofol-carprofen-halothane.
Topics: Anesthesia, General; Anesthetics, Combined; Anesthetics, General; Animals; Carbazoles; Dog Diseases; | 2013 |
Suspected carprofen toxicosis caused by coprophagia in a dog.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Coprophagia; Dog Diseases; Dogs; Femal | 2013 |
CT and PET-CT of a dog with multiple pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carbazoles; Dog Diseases; Dogs; Fatal Outcome; Fema | 2014 |
What is your diagnosis? Urine sediment changes in a dog with hemorrhagic shock and disseminated intravascular coagulation after pyometra surgery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Diagnosis, Differential; Disseminated | 2014 |
What is your diagnosis? Caudal cruciate avulsion fracture.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Female; Fractures, | 2015 |
Global positioning system derived performance measures are responsive indicators of physical activity, disease and the success of clinical treatments in domestic dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Female; Geographic | 2015 |
Transient unilateral vision loss in a dog following inadvertent intravitreal injection of bupivacaine during a dental procedure.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Local; Animals; Blindness; Bupivacaine; | 2015 |
Carprofen pharmacokinetics in plasma and in control and inflamed canine tissue fluid using in vivo ultrafiltration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Body Fluids; Carbazoles; Carrage | 2016 |
Effects of low molecular weight hyaluronan combined with carprofen on canine osteoarthritis articular chondrocytes and cartilage explants in vitro.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cartilage, Art | 2015 |
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carbazoles; Cell Line, Tumo | 2017 |
Dorsolateral spinal cord compression at the C2-C3 junction in two Cavalier King Charles spaniels.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Genetic Predisposi | 2011 |
Successful medical treatment of an orbital osteoma in a dog.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Male; Orbital Neop | 2013 |
Canine Trypanosoma evansi infection introduced into Germany.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Inflammatory Age | 2012 |
Long-term outcome of Cavalier King Charles spaniel dogs with clinical signs associated with Chiari-like malformation and syringomyelia.
Topics: Amines; Analgesics; Animals; Arnold-Chiari Malformation; Breeding; Carbazoles; Cohort Studies; Cyclo | 2012 |
Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis.
Topics: Animals; Carbazoles; Cartilage, Articular; Cells, Cultured; Chondrocytes; Collagenases; Dexamethason | 2002 |
Safety of Cartrophen Vet in the dog: review of adverse reaction reports in the UK.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Anti-Inflammatory Agents, Non-Steroidal; Breeding; | 2003 |
Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Carbazoles; | 2003 |
Fecal alpha1-proteinase inhibitor concentration in dogs receiving long-term nonsteroidal anti-inflammatory drug therapy.
Topics: alpha 1-Antitrypsin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Case-Control Stud | 2003 |
Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butorphanol; Carbazoles; Dog Diseas | 2003 |
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cyclooxygenase Inhibi | 2004 |
Neutrophilic dermatitis and immune-mediated haematological disorders in a dog: suspected adverse reaction to carprofen.
Topics: Adverse Drug Reaction Reporting Systems; Anemia, Hemolytic; Animals; Anti-Inflammatory Agents, Non-S | 2005 |
In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis.
Topics: Animals; Carbazoles; Cyclooxygenase Inhibitors; Dinoprostone; Dog Diseases; Dogs; Drug Administratio | 2005 |
Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a siberian husky.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Chemical and Drug Induced Liver Injury | 2005 |
Long-term treatment with carprofen of 805 dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Do | 2007 |
The effect of carprofen on selected markers of bone metabolism in dogs with chronic osteoarthritis.
Topics: Age Factors; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Bon | 2007 |
Influencing factors of ADP-induced, epinephrine-induced and ristomycin-induced platelet aggregation in dogs.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Case-Control St | 2008 |
Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cartilage, Articular; Cell Division; C | 1997 |
Hepatocellular toxicosis associated with administration of carprofen in 21 dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Carbazoles; Chemical and Drug Induced Live | 1998 |
Long-term temporal evaluation of ground reaction forces during development of experimentally induced osteoarthritis in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Carbazoles; Dog Diseases; | 2001 |